CardioGenics (CGNH) 10-Q2011 Q1 Quarterly report

Filed: 20 Jun 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: add, addressing, affirmative, aggressing, called, cancellation, deemed, ensure, extended, extent, forthwith, fourth, fullest, heard, longer, notwithstanding, prejudice, recommence, repriced, repricing, stage, TD, thereof, tort, trust, Voluntary

Removed: allocation, assumed, automatically, barred, closed, collectively, comprise, consideration, Corporation, direct, dividend, effected, exchangeable, ExchangeCo, exchanged, file, fully, holding, indirect, insure, issue, law, LLC, LLS, March, membership, moved, ownership, participate, Pixaya, privately, pro, rata, registered, registration, remain, repaid, resale, Rothcove, Rule, Section, sell, state, submit, subsidiary, transact, transaction, UK, voting

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

CGNH similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

Section 906 Certifications by the Chief Executive Officer and Chief Financial Officer

Each of Yahia Gawad, Chief Executive Officer, and James Essex, Chief Financial Officer, of CardioGenics Holdings Inc., a Nevada corporation (the “Company”) hereby certifies pursuant to 18 U.S.C. ss. 1350, as added by ss. 906 of the Sarbanes-Oxley Act of 2002, that, to their knowledge:

(1) The Company’s periodic report on Form 10-Q for the period ended April 30, 2011 (“Form 10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operation of the Company.

/s/ Yahia Gawad		/s/ James Essex

Name: Yahia Gawad Title: Chief Executive Officer		Name: James Essex Title: Chief Financial Officer

Date: June 20, 2011